Skip to main content
Book Now

How can I get vaginal dryness treatment online in Delaware?

TeleDirectMD provides board-certified physician video visits for vaginal dryness treatment to adult residents of Delaware. A same-day visit with Parth Bhavsar, MD (NPI: 1104323203) is $79 (cash-pay, no insurance required) — TeleDirectMD operates self-pay only in Delaware, with HSA and FSA accepted. Per ACOG Practice Bulletins, telehealth is clinically appropriate for uncomplicated vaginal dryness when red-flag symptoms are absent. For comparison, urgent care averages $150–$320 (BetterCare (2025)) and an emergency-room visit can exceed $1,200 for the same condition. Penn Medicine, JAMA Network Open (2024) found telehealth visits cost roughly five times less than in-person office visits ($96 vs $509 mean).
Medically reviewed by Parth Bhavsar, MD · Updated May 19, 2026

Delaware residents seeking same-day treatment for common illnesses can book a video visit with Parth Bhavsar, MD — board-certified Family Medicine — without leaving home. TeleDirectMD holds an active Delaware medical license (C1-0029257) issued by the Delaware Board of Medical Licensure and Discipline, verifiable through DELPROS at delpros.delaware.gov. Delaware's compact size — one of the most densely populated states in the country — still leaves many Delaware residents facing long waits at urgent care clinics in Wilmington, Dover, and Newark. A same-day Delaware telehealth visit costs $79 flat self-pay, with no insurance complexity, no prior auth, and no surprise billing. HSA and FSA cards are accepted. Adults 18 and older located anywhere in Delaware are eligible.

Vaginal Dryness Treatment via telehealth in Delaware:

TeleDirectMD offers same-day video visits with a board-certified MD for vaginal dryness treatment in Delaware, starting at $79. A physician evaluates your symptoms, confirms the diagnosis, and sends a prescription to your local pharmacy — no waiting room required.

Vaginal Dryness Treatment in Delaware (Genitourinary Syndrome of Menopause)

Delaware adult care by secure video visit, self pay option starting at $79, MD-only, insurance is not required.

Vaginal dryness is a hallmark symptom of genitourinary syndrome of menopause (GSM), the current medical term for vulvovaginal atrophy. GSM affects over 50 to 83 percent of postmenopausal women and is caused by declining estrogen levels that lead to thinning, drying, and inflammation of the vaginal and urogenital tissues. Symptoms include vaginal dryness, burning, itching, painful intercourse (dyspareunia), and urinary symptoms such as urgency and recurrent infections. Unlike hot flashes, which often improve over time, GSM is a chronic progressive condition that worsens without treatment. Low-dose vaginal estrogen is the gold standard for localized GSM symptoms and has minimal systemic absorption, making it preferred over systemic hormone replacement therapy when symptoms are limited to the vaginal and urinary area. TeleDirectMD uses a safety-first telehealth approach that screens for red flags including undiagnosed vaginal bleeding, suspected pelvic masses, pelvic organ prolapse, vulvar lesions, and history of estrogen-sensitive cancers before determining whether treatment by video visit is appropriate. If the history supports uncomplicated GSM without red flags, guideline-based treatment with vaginal estrogen, non-hormonal alternatives, or over-the-counter lubricants and moisturizers may be reasonable by video, while patients with red-flag symptoms or complex oncologic histories are directed to in-person gynecologic care. This page is for adults located in Delaware, including Wilmington, Dover, Newark, Middletown, Bear, Glasgow, Brookside, Hockessin, Smyrna, Milford, and surrounding areas.

Quick navigation:

  • Self pay option starting at $79
  • MD-only care (no mid-levels)
  • Insurance is not required
  • Licensed telehealth care for patients located in Delaware at the time of the visit

Last reviewed on 2026-06-14 by Parth Bhavsar, MD

ICD-10 commonly used: N95.2 (final coding depends on clinical details)

Online MD-Only Vaginal Dryness Care in Delaware

  • Evaluation of vaginal dryness, GSM symptoms, and severity
  • Red-flag screening for undiagnosed bleeding, cancer history, and pelvic pathology
  • Guideline-based prescription options including low-dose vaginal estrogen when appropriate
  • Ongoing management guidance and non-hormonal alternatives

Adults 18+ only. TeleDirectMD is not an emergency service. Seek in-person care now for heavy vaginal bleeding, severe pelvic pain, vaginal or vulvar masses, or any signs of serious illness. TeleDirectMD does not prescribe controlled substances.

Vaginal Dryness Telehealth Eligibility Checklist for Delaware

You are likely eligible for a TeleDirectMD video visit if ALL of these are true:

✓ You Are Eligible If

  • You are 18 years old or older
  • You are physically located in Delaware at the time of the visit
  • You have vaginal dryness, burning, itching, or pain with intercourse that you believe is related to menopause or hormonal changes
  • You do not have unexplained vaginal bleeding
  • You do not have known or suspected pelvic masses or organ prolapse
  • You do not have a personal history of estrogen-receptor-positive breast cancer without oncology clearance for vaginal estrogen
  • Insurance is not required. A self pay option is available.

✗ You Are Not Eligible If

  • You are under 18 years old
  • You have undiagnosed or unexplained vaginal bleeding
  • You have a known or suspected pelvic mass, pelvic organ prolapse, or vulvar lesions needing examination
  • You have a personal history of estrogen-dependent cancer without written oncology clearance
  • You have severe pelvic pain or suspected infection with fever
  • You have active deep vein thrombosis or pulmonary embolism
  • You need a pelvic exam, Pap smear, or endometrial biopsy

If you have red-flag symptoms, seek urgent in-person care or emergency care immediately. TeleDirectMD is not appropriate for complex or severe cases.

How Online Vaginal Dryness Treatment Works in Delaware

1

Book your video visit

Insurance is not required. No referral needed. Many visits are available same day, depending on scheduling. Before your visit, note when symptoms started, whether they are related to menopause or surgical changes, what treatments you have tried including over-the-counter lubricants and moisturizers, your menstrual status, any history of breast cancer or blood clots, and any current medications including hormone therapy.

2

See a Delaware licensed MD by video

We review your symptom pattern, menopausal status, prior treatments, bleeding history, cancer history, and risk factors. The NAMS 2020 position statement and AUA 2025 GSM guideline emphasize that symptom-based diagnosis is appropriate for classic GSM, and low-dose vaginal estrogen is the gold standard for localized symptoms with minimal systemic absorption.

3

Get a treatment plan and, if appropriate, a prescription

If medication is clinically appropriate, we send an e-prescription to common Delaware pharmacies such as CVS Pharmacy, Walgreens, Walmart Pharmacy, Rite Aid, Acme Pharmacy. You receive clear guidance on application technique, expected timeline for improvement, the importance of ongoing treatment for this chronic condition, and when to seek in-person care if symptoms do not improve.

Delaware Telehealth Regulations for Online Vaginal Dryness Care

Delaware Title 24 Chapter 60 and Section 1769D of the Medical Practice Act govern telemedicine services, permitting licensed physicians to provide telehealth care using audio-video telecommunications. Physicians must establish a proper physician-patient relationship, verify patient location and identity, obtain informed consent regarding telehealth delivery, and maintain complete medical records. Treatment recommendations and prescriptions issued via telehealth are held to the same standards of appropriate practice as in-person encounters.

Location matters: you must be physically in Delaware during the visit. Insurance is not required. TeleDirectMD does not prescribe controlled substances.

TeleDirectMD vs Other Care Options for Vaginal Dryness in Delaware

Here is how TeleDirectMD compares to common settings for vaginal dryness and GSM care in Delaware:

Care optionTypical costWait timeProvider typeBest for
TeleDirectMDSelf pay option starting at $79Same day, often within hoursBoard-certified MD only (no mid-levels)Classic GSM symptoms needing prescription vaginal estrogen or non-hormonal options with ongoing management guidance
Urgent Care$150 to $300+ (before insurance)1 to 3 hours typicalMD, DO, PA, or NPAcute vaginal symptoms with uncertain diagnosis needing exam, or suspected infection
Emergency Room$500 to $3,000+ (before insurance)2 to 6 hours typicalEmergency medicine MD or DOHeavy vaginal bleeding, severe pelvic pain, or signs of serious illness
Primary Care / Gynecology$100 to $350+ (varies)3 to 14 days typicalFamily medicine, internal medicine, or OB/GYN MD or DOPelvic exam, Pap smear, endometrial evaluation, complex cancer history, or systemic hormone therapy consideration
Menopause Specialist$200 to $500+ (varies)Weeks to months (varies)NAMS-certified menopause specialist or gynecologistComplex menopausal management, systemic HRT evaluation, breast cancer survivor GSM care, or refractory symptoms

Bottom line: TeleDirectMD is a strong fit for classic vaginal dryness and GSM symptoms that need prescription treatment, with a safety-first approach and direct MD evaluation.

Should I Use TeleDirectMD for Vaginal Dryness in Delaware? Decision Guide

1

Do you have any emergency or red-flag symptoms?

  • Undiagnosed or unexplained vaginal bleeding
  • Heavy vaginal bleeding or bleeding after menopause without evaluation
  • Severe pelvic pain, pelvic pressure, or suspected mass
  • Vulvar lesions, ulcers, or suspicious skin changes
  • Signs of serious illness such as fever with pelvic symptoms

If yes, seek urgent in-person care or the ER now

If no, continue to Step 2

2

Are you 18+ and currently in Delaware?

If yes, continue to Step 3

If no, use in-person care as appropriate

3

Do your symptoms fit genitourinary syndrome of menopause?

  • Vaginal dryness, burning, or irritation
  • Painful intercourse (dyspareunia)
  • Urinary urgency, frequency, or recurrent UTIs associated with menopause
  • Symptoms started or worsened around menopause, surgical menopause, or hormonal changes

If yes, continue to Step 4

If no or symptoms are severe, seek in-person evaluation

4

You are likely appropriate for a TeleDirectMD video visit

TeleDirectMD can evaluate GSM symptoms, confirm safety for telehealth, discuss the most effective treatment options including low-dose vaginal estrogen and non-hormonal alternatives, and prescribe medication when clinically appropriate. If your symptoms suggest a different diagnosis or any red flags are present, we will direct you to the right level of in-person care.

What Does Vaginal Dryness Treatment Cost in Delaware?

Transparent options. Insurance is not required.

TeleDirectMD Video Visit

$79

Self pay option. Insurance is not required.

  • MD evaluation and red-flag screening
  • Assessment of GSM severity, menopausal status, and treatment history
  • Guideline-based medication selection including vaginal estrogen and non-hormonal options
  • Prescription sent if clinically appropriate
  • Ongoing management guidance and follow-up recommendations

Typical Cost Comparison

Common ranges people see before insurance. Actual costs vary.

TeleDirectMD$79
Primary Care$100 to $350+
Urgent Care$150 to $300+
Emergency Room$500 to $3,000+

Prescription costs at your pharmacy are separate and vary by medication and pharmacy.

No hidden fees. If medication is not clinically appropriate, you still receive a complete evaluation, guidance, and clear instructions on what level of care you need next.

What Is Vaginal Dryness (GSM)?

Vaginal dryness is the most common symptom of genitourinary syndrome of menopause (GSM), formerly called vulvovaginal atrophy or atrophic vaginitis. GSM is caused by declining estrogen levels during menopause, which leads to thinning of vaginal tissue, loss of elasticity, decreased lubrication, and changes in the vaginal pH that increase susceptibility to infections.

GSM affects over 50 to 83 percent of postmenopausal women, yet it remains significantly underreported and undertreated. Unlike vasomotor symptoms such as hot flashes, which often improve with time, GSM is a chronic progressive condition that worsens without treatment. Symptoms include vaginal dryness, burning, itching, irritation, painful intercourse, and urinary symptoms including urgency, frequency, and recurrent urinary tract infections.

TeleDirectMD focuses on uncomplicated GSM symptoms appropriate for telehealth, with careful screening to direct patients with undiagnosed vaginal bleeding, suspected pelvic pathology, or complex oncologic histories to in-person gynecologic care.

Causes and Risk Factors

GSM is primarily caused by declining estrogen levels that affect the vaginal, vulvar, and urinary tissues. Understanding the underlying causes helps guide treatment selection and determine whether telehealth evaluation is appropriate or in-person gynecologic evaluation is needed.

  • Natural menopause: estrogen levels decline gradually during perimenopause and drop significantly after menopause, leading to progressive vaginal tissue changes
  • Surgical menopause: bilateral oophorectomy causes abrupt estrogen loss, often producing more severe and rapid-onset GSM symptoms
  • Cancer treatments: chemotherapy, pelvic radiation, and aromatase inhibitors or anti-estrogen therapies can cause or worsen GSM symptoms
  • Breastfeeding: lactation-related estrogen suppression can cause temporary vaginal dryness that typically resolves after weaning
  • Smoking: tobacco use is associated with earlier menopause and more severe GSM symptoms through anti-estrogenic effects

Not every vaginal symptom is GSM. Yeast infections, bacterial vaginosis, contact dermatitis from soaps or hygiene products, sexually transmitted infections, and vulvar skin conditions such as lichen sclerosus can mimic GSM symptoms. TeleDirectMD uses symptom patterns, menopausal history, and safety screening to distinguish GSM from conditions that require in-person evaluation.

Symptoms and Red Flags for Vaginal Dryness in Delaware

Use this table to understand which symptoms fit genitourinary syndrome of menopause and which symptoms suggest a need for urgent in-person evaluation.

Symptom or situationWhat it suggestsTelehealth appropriate?Red flag requiring urgent in-person care
Vaginal dryness, burning, or irritation worsening after menopauseClassic GSM from estrogen declineOften yesIf accompanied by unexplained vaginal bleeding
Painful intercourse (dyspareunia) with decreased lubricationVaginal atrophy with loss of tissue elasticityOften yesIf severe pain with bleeding, mass, or structural concern
Urinary urgency, frequency, or recurrent UTIs after menopauseUrogenital atrophy affecting the urethra and bladderOften yesIf hematuria, fever, flank pain, or urinary retention
Vaginal itching without dischargeGSM, contact dermatitis, or vulvar skin conditionSometimesIf visible lesions, ulcers, or skin changes needing exam
Postmenopausal vaginal bleedingMust rule out endometrial pathologyNoUrgent in-person evaluation required for any postmenopausal bleeding
Pelvic pressure, heaviness, or bulging sensationPossible pelvic organ prolapseNoIn-person pelvic exam needed
Vaginal discharge with odor, abnormal color, or feverPossible infection (BV, yeast, STI) rather than GSMSometimesIf fever, severe pain, or concern for pelvic infection

Differential Diagnosis: Vaginal Dryness vs Other Conditions

Several conditions can mimic GSM symptoms. The NAMS 2020 position statement emphasizes that accurate diagnosis is essential before initiating hormonal therapy, and that infections, dermatologic conditions, and malignancy should be excluded when appropriate. TeleDirectMD focuses on identifying classic GSM and directing alternative diagnoses to targeted care.

Sometimes Appropriate for Telehealth

  • Classic GSM symptoms with clear menopausal history and no red flags
  • Mild to moderate vaginal dryness responding to OTC lubricants or needing step-up therapy
  • Prescription vaginal estrogen initiation or refill for established GSM
  • Non-hormonal treatment options for patients who cannot or prefer not to use estrogen
  • Ongoing management and follow-up for previously diagnosed GSM

Often Requires In-Person Evaluation

  • Undiagnosed postmenopausal vaginal bleeding needing endometrial evaluation
  • Vulvar lesions, ulcers, or suspected lichen sclerosus needing biopsy
  • Suspected pelvic organ prolapse needing physical exam
  • Breast cancer survivors needing oncology clearance before vaginal estrogen
  • Recurrent urinary tract infections needing urology or gynecology workup

GSM vs Yeast Infection

GSM causes chronic vaginal dryness, burning, and irritation that worsens progressively after menopause and does not resolve without treatment. Yeast infections cause acute itching with thick white discharge and typically respond to antifungal treatment within days. Some menopausal patients develop recurrent yeast infections because the altered vaginal pH of GSM increases susceptibility to candidal overgrowth.

GSM vs Bacterial Vaginosis

GSM causes dryness and irritation without significant discharge, while bacterial vaginosis causes thin grayish discharge with a fishy odor. Both conditions involve changes in vaginal pH. GSM raises vaginal pH due to estrogen loss, while BV raises pH due to overgrowth of anaerobic bacteria. The two conditions can co-occur, especially in postmenopausal women.

GSM vs Contact Dermatitis

GSM causes progressive dryness and irritation related to menopause. Vulvar contact dermatitis causes itching, burning, and redness from soaps, laundry detergents, hygiene products, or panty liners. Contact dermatitis typically improves with allergen avoidance, while GSM requires ongoing hormonal or non-hormonal treatment.

If your symptoms do not match classic GSM or any red flags are present, TeleDirectMD will direct you to in-person gynecologic or dermatologic care as appropriate.

When Is a Video Visit Appropriate?

When a Video Visit Is Appropriate

  • Typical GSM symptoms (vaginal dryness, burning, dyspareunia, urinary symptoms) with clear menopausal association
  • No unexplained vaginal bleeding
  • No known or suspected pelvic masses or prolapse
  • No history of estrogen-sensitive cancer without oncology clearance
  • Looking for prescription vaginal estrogen or non-hormonal treatment options
  • Located in Delaware at time of visit

Red Flags Requiring In-Person or ER Care

  • Any undiagnosed postmenopausal vaginal bleeding
  • Severe pelvic pain, pressure, or suspected mass
  • Vulvar lesions, ulcers, or suspicious skin changes
  • Pelvic organ prolapse symptoms (bulging, heaviness)
  • History of estrogen-receptor-positive breast cancer without oncology clearance
  • Heavy vaginal bleeding or signs of serious illness

If any red-flag symptoms are present, seek urgent in-person or emergency care. TeleDirectMD is not appropriate for these situations.

Treatment Options

GSM treatment follows NAMS 2020 and AUA 2025 guidelines with a stepwise approach. Over-the-counter lubricants and moisturizers are first-line for mild symptoms. Low-dose vaginal estrogen is the gold standard for moderate to severe localized GSM symptoms and has minimal systemic absorption, making it preferred over systemic hormone replacement therapy when symptoms are limited to the vaginal and urogenital area. Treatment is ongoing because GSM is a chronic progressive condition and symptoms return when treatment is stopped.

OTC lubricants and moisturizers (first-line for mild symptoms)

Water-based, silicone-based, or oil-based vaginal lubricants reduce friction and discomfort during sexual activity. Vaginal moisturizers containing hyaluronic acid or polycarbophil are applied regularly 2 to 3 times per week to maintain vaginal hydration regardless of sexual activity. These are available without prescription and are appropriate as initial treatment for mild dryness.

Low-dose vaginal estrogen (gold standard for moderate to severe symptoms)

Low-dose vaginal estrogen is the most effective treatment for localized GSM symptoms. It restores vaginal tissue thickness, elasticity, lubrication, and healthy pH. Options include vaginal estrogen cream, vaginal inserts (tablets), and vaginal rings. A key point is that vaginal estrogen at low doses has minimal systemic absorption, meaning it acts primarily on local tissues rather than throughout the body, making it preferred over systemic hormone therapy for vaginal-only symptoms.

Non-estrogen prescription options

For patients who cannot or prefer not to use estrogen, alternatives include prasterone (DHEA vaginal inserts), which is converted locally to estrogen and testosterone, and ospemifene (Osphena), an oral selective estrogen receptor modulator (SERM) that acts on vaginal tissue. These options are appropriate for patients with certain cancer histories or estrogen concerns when discussed with their oncologist.

Lifestyle and ongoing management

Regular sexual activity or vaginal stimulation helps maintain vaginal health. Avoid irritants such as scented soaps, douches, and harsh hygiene products. Use pH-balanced products. Treatment for GSM should be continued long-term because symptoms return when treatment is stopped. Follow up if symptoms are not improving within 4 to 12 weeks to discuss dosage adjustment or alternative options.

What TeleDirectMD Does Not Manage

  • Undiagnosed postmenopausal vaginal bleeding needing endometrial evaluation
  • Systemic menopausal symptoms (hot flashes, night sweats) needing systemic HRT evaluation
  • Pelvic organ prolapse needing surgical consultation
  • Breast cancer survivors needing oncology-coordinated GSM management

Common Medication Options

These are common examples for genitourinary syndrome of menopause. The actual medication, dose, and duration are determined by the MD after reviewing your symptoms, menopausal status, cancer history, bleeding history, and other medical conditions.

MedicationTypical doseDurationKey considerations
Estradiol vaginal cream (Estrace or generic)0.5 to 1 g intravaginally daily for 2 weeks, then 2 to 3 times per weekOngoing (chronic condition)Gold standard topical estrogen. Minimal systemic absorption at low doses. Use measured applicator for accurate dosing. Improvement begins within 2 to 4 weeks, full effect at 4 to 12 weeks.
Estradiol vaginal insert (Vagifem, Yuvafem, or generic)10 mcg intravaginally daily for 2 weeks, then twice weeklyOngoing (chronic condition)Low-dose vaginal tablet. Very low systemic absorption. Convenient for patients who prefer a tablet over cream. Same efficacy as vaginal cream for most patients.
Estradiol vaginal ring (Estring)7.5 mcg per day released continuously, ring replaced every 90 daysOngoing (replaced every 3 months)Self-inserted flexible ring that provides continuous low-dose estrogen. Minimal systemic absorption. Convenient for patients who prefer not to use daily or weekly applications.
Conjugated estrogen cream (Premarin vaginal)0.5 g intravaginally daily for 2 weeks, then 2 to 3 times per weekOngoing (chronic condition)Alternative vaginal estrogen cream. Same low systemic absorption profile. Some patients prefer this formulation. Use measured applicator.
Prasterone vaginal insert (Intrarosa)6.5 mg intravaginally once nightlyOngoing (chronic condition)DHEA insert converted locally to estrogen and testosterone. Non-estrogen option for patients with estrogen concerns. May be appropriate for some breast cancer survivors after oncology discussion.
Ospemifene (Osphena)60 mg by mouth once daily with foodOngoing (chronic condition)Oral SERM for moderate to severe dyspareunia. Non-estrogen systemic option. Contraindicated in patients with undiagnosed vaginal bleeding, breast cancer, or active DVT/PE. May cause hot flashes.

Important: Example regimens only. The actual medication, dosing, and duration are determined by the MD after reviewing your symptoms, menopausal status, cancer history, and risk factors. GSM is a chronic condition requiring ongoing treatment. TeleDirectMD does not prescribe controlled substances.

Home Care, Recovery Timeline, Prevention, and Follow-up

What to Do Now and Recovery Timeline

  • Begin using vaginal lubricant during sexual activity and vaginal moisturizer 2 to 3 times per week if not already doing so
  • If prescribed vaginal estrogen, use the measured applicator and apply at bedtime for best absorption
  • Improvement typically begins within 2 to 4 weeks, with full effect at 4 to 12 weeks of consistent use
  • Continue treatment long-term because GSM is chronic and symptoms return when treatment is stopped
  • Avoid douching, scented soaps, and harsh vulvar hygiene products that can worsen irritation

What to Watch For

  • Any vaginal bleeding while using vaginal estrogen requires prompt in-person evaluation to rule out endometrial pathology
  • If symptoms do not improve after 4 to 12 weeks of consistent vaginal estrogen use, reassessment is needed
  • New pelvic pain, pressure, or sensation of bulging may suggest pelvic organ prolapse and needs in-person evaluation
  • Signs of vaginal infection (new discharge, odor, or worsening symptoms) may need separate treatment
  • Breast tenderness or other systemic symptoms while using vaginal estrogen should be reported to your physician

Prevention and Follow-up

  • Continue vaginal estrogen or non-hormonal treatment as directed because stopping treatment leads to symptom recurrence
  • Regular sexual activity or vaginal stimulation helps maintain vaginal tissue health alongside medical treatment
  • Use pH-balanced vaginal moisturizers between estrogen applications for additional comfort
  • Schedule in-person gynecologic evaluation if you develop any new bleeding, pelvic symptoms, or vulvar changes
  • Discuss with your MD whether you are due for cervical cancer screening or mammography during your visit

When Not to Use TeleDirectMD for Vaginal Dryness in Delaware

TeleDirectMD is designed for uncomplicated GSM symptoms. We are direct about when telehealth is not appropriate.

You Should Not Use TeleDirectMD If

  • You are under 18 years old
  • You have undiagnosed or unexplained vaginal bleeding, especially after menopause
  • You have a known or suspected pelvic mass or pelvic organ prolapse
  • You have vulvar lesions, ulcers, or suspicious skin changes needing examination
  • You have a history of estrogen-receptor-positive breast cancer and have not received oncology clearance for vaginal estrogen
  • You have active deep vein thrombosis or pulmonary embolism
  • You need a pelvic exam, Pap smear, or endometrial biopsy
  • You are not physically in Delaware at the time of visit

Alternative Care Options

  • Emergency room: heavy vaginal bleeding, severe pelvic pain, or signs of serious illness
  • Urgent care: new vaginal bleeding needing same-day evaluation, or suspected vaginal or pelvic infection with fever
  • Gynecology: pelvic exam, endometrial evaluation, Pap smear, pelvic organ prolapse assessment, or vulvar biopsy
  • Menopause specialist: complex GSM management, systemic hormone therapy evaluation, or breast cancer survivor GSM care requiring oncology coordination

Practicing in Delaware

Parth Bhavsar, MD — board-certified Family Medicine — holds an active Delaware medical license (C1-0029257) issued February 17, 2026, by the Delaware Board of Medical Licensure and Discipline (DSBMLD), operating under the Delaware Division of Professional Regulation. The DSBMLD's statutory authority derives from Delaware Code Title 24, Chapter 17, and telehealth practice in Delaware is currently governed by Delaware Code Title 24, Chapter 60 (§§ 6001–6010), the Provisions Applicable to Telehealth and Telemedicine, effective July 1, 2021. Delaware patients may independently verify Dr. Bhavsar's Delaware license through the DELPROS online portal. The license expires March 31, 2027. NPI: 1104323203.

TeleDirectMD serves adults located anywhere in Delaware across all three counties. New Castle County — Delaware's most populous — includes Wilmington (Delaware's largest city), Newark (home to the University of Delaware), Bear, Hockessin, Pike Creek, and Middletown. Kent County's county seat is Dover, Delaware's capital, which anchors the central part of the state; Smyrna, Milford, and Harrington are also served. Sussex County, the southernmost and largest county by area, includes Georgetown (the county seat), Seaford, Laurel, Milford, and the Atlantic coastal resort communities of Rehoboth Beach and Lewes. Delaware has no frontier counties; all regions have established broadband infrastructure and pharmacy access for e-prescription fulfillment.

Delaware is classified by the CDC as a high-incidence Lyme disease jurisdiction, with 298 confirmed cases reported in 2022 (down from a 2017–2019 average of 590 annually per MMWR Vol. 73 No. 6, Feb. 2024). The black-legged tick (Ixodes scapularis) is established throughout Delaware's wooded areas, particularly in New Castle and Sussex counties. Delaware's mid-Atlantic position and humid summers drive moderate-to-high seasonal allergy burden: ragweed peaks August through October statewide, with tree pollen (oak, maple, birch) peaking March through May in northern Delaware. Sussex County's Atlantic coastal beaches — including Rehoboth Beach, Bethany Beach, and Dewey Beach — create elevated UV exposure risk for southern Delaware residents and seasonal visitors. Delaware's Division of Public Health (DPH), within the Delaware Department of Health and Social Services (DHSS), maintains statewide surveillance for reportable communicable diseases including influenza, Lyme disease, and sexually transmitted infections under Delaware's Communicable Disease regulations (16 Del. C. Chapter 5).

TeleDirectMD operates self-pay only in Delaware — no commercial insurance, no Medicaid, no Medicare. Every Delaware visit is $79 flat self-pay, paid at booking. There are no hidden fees, facility charges, or follow-up bills. HSA and FSA debit cards are accepted. Delaware patients with commercial insurance may still book TeleDirectMD telehealth at the $79 flat rate; the visit is paid out-of-pocket and may be submitted to the patient's plan for out-of-network reimbursement at the patient's discretion, though TeleDirectMD does not guarantee reimbursement and does not file insurance claims on behalf of Delaware patients. Delaware Medicaid beneficiaries — including those enrolled with Highmark Health Options, AmeriHealth Caritas Delaware, or Delaware First Health — should contact their MCO to locate in-network telehealth options.

Vaginal Dryness Treatment FAQs for Delaware

Can I get a prescription for vaginal dryness online in Delaware?

Yes, if you are an adult 18+ located in Delaware and your symptoms are appropriate for telehealth after red-flag screening. TeleDirectMD can prescribe low-dose vaginal estrogen cream, vaginal estrogen inserts, vaginal DHEA inserts, and other GSM treatments when clinically appropriate.

How much does online vaginal dryness treatment cost in Delaware?

TeleDirectMD offers a transparent self pay option starting at $79 for an adult video visit in Delaware. Insurance is not required. Prescription costs at your pharmacy are separate and vary by medication and pharmacy.

What is the most effective treatment for vaginal dryness after menopause?

Low-dose vaginal estrogen is the gold standard treatment for vaginal dryness caused by GSM. It restores vaginal tissue thickness, lubrication, and healthy pH with minimal systemic absorption. Options include vaginal estrogen cream, inserts, and rings. For mild symptoms, over-the-counter vaginal lubricants and moisturizers are a reasonable first step.

Is vaginal estrogen safe? Does it have the same risks as systemic hormone therapy?

Low-dose vaginal estrogen has minimal systemic absorption and is considered safe for most women, including many who cannot use systemic hormone therapy. The NAMS 2020 position statement and AUA 2025 guideline confirm that vaginal estrogen at recommended doses does not carry the same risks as systemic estrogen. However, women with a history of estrogen-receptor-positive breast cancer should discuss vaginal estrogen with their oncologist before starting.

How long does it take for vaginal estrogen to work?

Most women notice improvement within 2 to 4 weeks of starting vaginal estrogen, with full effect at 4 to 12 weeks of consistent use. It is important to continue treatment long-term because GSM is a chronic progressive condition and symptoms return when treatment is stopped.

Will vaginal dryness get better on its own?

No. Unlike hot flashes, which often improve over time, GSM is a chronic progressive condition that worsens without treatment. The vaginal and urogenital tissues continue to thin and lose elasticity as estrogen levels remain low after menopause. Treatment is needed to restore and maintain tissue health.

What are non-hormonal options for vaginal dryness?

Non-hormonal options include over-the-counter vaginal lubricants for use during sexual activity, vaginal moisturizers containing hyaluronic acid for regular use, and prescription options including prasterone (DHEA vaginal inserts) and ospemifene (an oral SERM). These may be appropriate for patients who cannot or prefer not to use estrogen.

Can I use vaginal estrogen if I have had breast cancer?

This depends on the type of breast cancer and your oncologist's recommendation. Some breast cancer survivors can safely use low-dose vaginal estrogen, while others should use non-hormonal alternatives. The AUA 2025 GSM guideline notes that low-dose vaginal estrogen can be used in some breast cancer survivors after discussion with the oncology team. TeleDirectMD will ask about your cancer history and recommend appropriate next steps.

Do I need a pelvic exam before starting vaginal estrogen?

Not always for initiating treatment in classic GSM cases. NAMS and AUA guidelines support symptom-based diagnosis for classic GSM when the clinical history is clear. However, a pelvic exam is needed if you have undiagnosed vaginal bleeding, vulvar lesions, suspected prolapse, or if the diagnosis is uncertain. TeleDirectMD will determine during your visit whether in-person examination is recommended.

Does TeleDirectMD treat vaginal dryness in other states?

Yes. TeleDirectMD offers adult evaluations via video visits across multiple states where our physicians are licensed. You must be physically located in the state where you are requesting care at the time of your video visit.

Can I use my insurance for a TeleDirectMD visit?

Insurance is not required. If your plan is eligible, you may be able to use insurance. A self pay option is also available.

What if my symptoms are not improving with vaginal estrogen?

If symptoms do not improve after 4 to 12 weeks of consistent vaginal estrogen use, reassessment is recommended. The dose or formulation may need adjustment, an alternative diagnosis may need to be considered, or an in-person pelvic exam may be needed. Some patients benefit from combination therapy or switching from cream to a ring or insert.

Is vaginal dryness the same as menopause?

Vaginal dryness is one symptom of the genitourinary effects of menopause, now called GSM. Menopause itself is defined as 12 consecutive months without a menstrual period and involves many changes beyond vaginal dryness, including hot flashes, sleep disruption, and mood changes. GSM specifically refers to the chronic progressive changes in vaginal, vulvar, and urinary tissues caused by estrogen decline.

Can younger women have vaginal dryness?

Yes. While GSM is most common after menopause, younger women can experience vaginal dryness from breastfeeding, certain medications (aromatase inhibitors, some birth control methods), cancer treatments, surgical removal of the ovaries, or conditions that suppress estrogen. The evaluation approach is similar, but the underlying cause guides treatment selection.

Do you accept Delaware Medicaid — including Highmark Health Options, AmeriHealth Caritas Delaware, or Delaware First Health?

TeleDirectMD does not currently accept Delaware Medicaid managed care plans. Delaware Medicaid is administered through three managed care organizations: Highmark Health Options, AmeriHealth Caritas Delaware, and Delaware First Health. None of these MCOs are currently in TeleDirectMD's Delaware network. Delaware Medicaid beneficiaries may visit dhss.delaware.gov or contact their MCO directly to find covered telehealth providers. The $79 flat self-pay rate is available to all Delaware patients regardless of Medicaid status.

Is telehealth legal for treating conditions like sinus infections, UTIs, and allergies in Delaware?

Yes. Delaware Code Title 24, Chapter 60 (effective July 1, 2021) authorizes Delaware-licensed physicians to deliver clinical health-care services via real-time audio-visual telehealth without a prior in-person visit, provided the physician establishes a proper provider-patient relationship through audio-visual evaluation meeting the standard of care. Common conditions — including acute bacterial sinusitis, uncomplicated UTI, seasonal allergies, pink eye, and skin conditions — are routinely appropriate for telehealth evaluation in Delaware. Dr. Bhavsar holds an active Delaware medical license (C1-0029257) from the Delaware Board of Medical Licensure and Discipline (DSBMLD).

Which Delaware pharmacies will receive my prescription?

TeleDirectMD transmits prescriptions electronically under Delaware's mandatory e-prescribing law (24 Del. C. § 1764A). You choose any Delaware pharmacy at booking: CVS locations throughout Wilmington, Newark, Dover, and Sussex County; Walgreens (including former Happy Harry's Delaware locations); Walmart Pharmacy in Bear, Dover, Middletown, and Seaford; Acme Markets pharmacy in northern Delaware; and Rite Aid in select Delaware communities. Your prescription is routed directly to your chosen Delaware pharmacy, typically ready within one to two hours.

Are TeleDirectMD physicians licensed in Delaware? How do I verify?

Yes. Parth Bhavsar, MD — board-certified Family Medicine — holds Delaware medical license C1-0029257, issued February 17, 2026, by the Delaware Board of Medical Licensure and Discipline (DSBMLD) under the Delaware Division of Professional Regulation. You can independently verify this license at any time through the DELPROS portal at delpros.delaware.gov. The license is active and expires March 31, 2027. TeleDirectMD complies with all Delaware telehealth practice requirements under 24 Del. C. Chapter 60.

Where in Delaware do you serve patients — is TeleDirectMD available in all three counties?

TeleDirectMD serves adults 18+ located anywhere in Delaware during the visit — in all three counties. New Castle County: Wilmington, Newark, Bear, Hockessin, Pike Creek, and Middletown. Kent County: Dover (Delaware's capital), Smyrna, Harrington, and Milford. Sussex County: Georgetown, Seaford, Laurel, Rehoboth Beach, Lewes, and surrounding communities. Delaware has no frontier or access-restricted areas. All visits require the patient to be physically in Delaware at the time of the telehealth encounter per 24 Del. C. § 6004.

What if I'm in Delaware and need a controlled-substance medication — can TeleDirectMD prescribe it?

No. Per the federal Ryan Haight Online Pharmacy Consumer Protection Act and Delaware prescribing standards, TeleDirectMD does not prescribe DEA-controlled substances (Schedules II–V) — including opioids, benzodiazepines, stimulants (ADHD medications), or sleep medications — via telehealth without a prior in-person physician-patient relationship. Delaware Code Title 24, Chapter 60 permits telehealth prescribing subject to Board limitations. Delaware's Prescription Monitoring Program (PMP), authorized under 16 Del. C. § 4798 and administered by the Office of Controlled Substances, tracks all controlled substance prescriptions in the state. For controlled substances, patients should contact their in-person Delaware primary care physician or a Delaware urgent care facility.

Need help today?

Insurance is not required. Adult-only video visits. MD-only care. Safety-first triage, prescription vaginal dryness treatment, and clear next steps.

TeleDirectMD Telehealth Disclaimer

TeleDirectMD provides MD-only virtual urgent care for adults (18+) in Delaware using secure video visits to evaluate vaginal dryness and GSM symptoms, provide evidence-based guidance, and prescribe vaginal estrogen or non-hormonal treatment when clinically appropriate. Insurance is not required. You must be physically located in Delaware at the time of your video visit. TeleDirectMD does not prescribe controlled substances.

TeleDirectMD is not an emergency service and is not a replacement for urgent in-person care during heavy vaginal bleeding, severe pelvic pain, or suspected malignancy. This service is intended for uncomplicated GSM symptoms and is not a substitute for pelvic examination, endometrial evaluation, or oncology-coordinated care when red flags are present.

Online vaginal dryness treatment in Delaware. GSM treatment online. Vaginal atrophy treatment by video visit. Vaginal estrogen prescription online in Delaware.

Get Vaginal Dryness Treatment Treatment in Other States

TeleDirectMD treats vaginal dryness treatment via telehealth in 40+ states. If you are traveling, relocating, or helping a family member in another state, select below to find this treatment near them.

What does an online doctor visit in Delaware cost?

TeleDirectMD's $79 flat rate is up to 3× cheaper than an in-person urgent care visit and ~11× cheaper than an uninsured ER visit. See verified 2026 cash-pay prices across every care setting.

$79 Flat FeeInsurance accepted in select states
Book Now